Choriocapillaris Activation in Macular Degeneration
Choriocapillaris Activation in Macular Degeneration
批准号:
8118503
负责人:
Robert Foster Mullins
金额:
$35.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-15 至 2013-07-31
关键词:
AffectAgeAge related macular degenerationAnaphylatoxinsAreaBehaviorBiochemistryBioinformaticsBlindnessBlood VesselsCandidate Disease GeneCell Culture TechniquesCell Surface ProteinsCellsChoroidComplementComplement 3aComplement 5aComplexComputersDevelopmentDiseaseElderlyEndothelial CellsEngineeringEventExposure toEyeGenesGeneticGenetic PolymorphismGenotypeGrantGrowthHumanImmunohistochemistryIn VitroInfiltrationInflammationInjuryLeukocytesMacular degenerationMediatingMessenger RNAMethodologyMicroarray AnalysisMicroscopyMissionMolecularMutationNational Eye InstituteNatureOrgan Culture TechniquesPathogenesisPatientsPatternPlayPopulationPrevalenceProteinsReverse Transcriptase Polymerase Chain ReactionRiskRoleScreening procedureSingle Nucleotide PolymorphismSocietiesSystemTestingTimeTissuesTranscriptVisionVision researchWestern BlottingWestern Worldcohortcomplement systemfollow-upimmunocytochemistryresearch studyresponse
中文摘要
年龄相关性黄斑变性(AMD)是西方世界无法治愈的失明的主要原因,仅在美国就有数百万人受到影响。随着人口的老龄化,AMD对社会的负面影响会越来越大。不幸的是,AMD的发病机制目前尚不清楚。由于黄斑变性的流行及其对视力的严重损害,评估黄斑变性的发病机制是国家眼科研究所的任务之一,并在2004年国家眼与视力研究计划中得到强调。
英文摘要
DESCRIPTION: Age-related macular degeneration (AMD) is the leading cause of untreatable blindness in the Western world, with millions affected in the U.S. alone. As the population ages, the negative impact of AMD on society will increase. Unfortunately, the pathogenesis of AMD is currently poorly understood. Because of the prevalence of AMD, and its severe toll on vision, evaluating disease mechanisms in AMD is part of the mission of the National Eye Institute and is highlighted in the 2004 National Plan for Eye and Vision Research.
In this project we will examine the role of choriocapillaris activation molecules in AMD. In view of the role of inflammation and the complement system in AMD, we propose to explore the hypothesis that activation of choriocapillaris endothelial cells may be a central event in the pathogenesis of this disease.
The first specific aim of this project is to examine the extent and nature of endothelial cell activation in normal eyes and eyes with AMD. Ongoing molecular and histological studies will be performed on normal eyes, early AMD eyes, and advanced AMD eyes.
In the second specific aim we will determine whether endothelial cells become activated in culture following exposure to microenvironmental insults that are likely to occur in AMD. Endothelial cell cultures will be challenged with complement complexes (using methodology we have developed) and complement byproducts (anaphylatoxins). The activation response of these cells will be studied using microarrays, immunocytochemistry, real time PCR and Western blotting.
In the third specific aim we will test the hypothesis that mutations or polymorphisms in the genes encoding endothelial activation molecules are associated with AMD using a bioinformatics-driven approach. Single nucleotide polymorphisms will be screened in 30 candidate genes (6 per year of the grant). Genetic findings will be followed up using immunohistochemistry and Western blotting of human eyes to examine the possible functional consequences of specific genotypes.
Summary: The endothelial cells that comprise blood vessels are likely to play an important role in AMD. One way that these cells promote inflammation is by attracting white blood cells into the inflamed tissue. Endothelial cells perform this role through expression of cell surface proteins that increase in abundance during endothelial "activation". We hypothesize that endothelial cell activation in the eye is responsible for the tissue injury and abnormal blood vessel growth in this disease. Interdisciplinary experiments involving genetics, computer engineering, biochemistry, cell culture and microscopy are expected to provide new information about the potential role of choriocapillaris activation in the development of AMD.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/978-1-4614-3209-8_36
发表时间:
2014-01-01
期刊:
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY
影响因子:
--
作者:
[Mullins, Robert F., Khanna, Aditi, Stone, Edwin M.]
通讯作者:
Stone, Edwin M.
DOI:
10.1167/iovs.12-11454
发表时间:
2013
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[Christopher,Mark, Scheetz,ToddE, Mullins,RobertF, Abràmoff,MichaelD]
通讯作者:
Abràmoff,MichaelD
Stem cells as tools for studying the genetics of inherited retinal degenerations.
干细胞作为研究遗传性视网膜变性遗传学的工具。
DOI:
10.1101/cshperspect.a017160
发表时间:
2014
期刊:
Cold Spring Harbor perspectives in medicine
影响因子:
5.4
作者:
[Wiley,LukeA, Burnight,ErinR, Mullins,RobertF, Stone,EdwinM, Tucker,BuddA]
通讯作者:
Tucker,BuddA
DOI:
10.1038/eye.2008.206
发表时间:
2009-04
期刊:
Eye (London, England)
影响因子:
--
作者:
[Skeie JM, Mullins RF]
通讯作者:
Mullins RF
Anti-γ-enolase autoimmune retinopathy manifesting in early childhood.
抗γ-烯醇化酶自身免疫性视网膜病表现在儿童早期。
DOI:
10.1001/archophthalmol.2010.295
发表时间:
2010
期刊:
Archives of ophthalmology (Chicago, Ill. : 1960)
影响因子:
--
作者:
[Ko,AudreyC, Hernández,Jasmine, Brinton,JasonP, Faidley,ElizabethA, Mugge,SarahA, Mets,MarilynB, Kardon,RandyH, Folk,JamesC, Mullins,RobertF, Stone,EdwinM]
通讯作者:
Stone,EdwinM
共 14 条
Molecular Studies of the Choriocapillaris in AMD
-
批准号:10338267
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Studies of the Choriocapillaris in AMD
-
批准号:10541173
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
A Next Generation Outer Retinal Microphysiological System
-
批准号:10614641
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
A Next Generation Outer Retinal Microphysiological System
-
批准号:10444742
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Imaging Core
-
批准号:10663390
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2016
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Imaging Core
-
批准号:10488230
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2016
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Imaging Core
-
批准号:10271730
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2016
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris protection and replacement in AMD
-
批准号:10397546
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Protection and Replacement in AMD
-
批准号:8752902
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Protection and Replacement in AMD
-
批准号:8895955
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris protection and replacement in AMD
-
批准号:9920151
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Protection and Replacement in AMD
-
批准号:10734878
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7318536
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7495509
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7665360
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7905688
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
The Choriocapillaris in Aging and Macular Disease
-
批准号:6734677
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2003
-
负责人:Robert Foster Mullins
-
依托单位:
The Choriocapillaris in Aging and Macular Disease
-
批准号:6597402
-
项目类别:
-
资助金额:$14.74万
-
财政年份:2003
-
负责人:Robert Foster Mullins
-
依托单位:
The Choriocapillaris in Aging and Macular Disease
-
批准号:6888050
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2003
-
负责人:Robert Foster Mullins
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: